The recall affects one lot of ICU Medical’s lactated ringer’s injection and one lot of its 0.9 percent sodium chloride injection. Both products replace losses of fluids or electrolytes in patients.
The recall was initiated after particulate matter was discovered in the injections.
ICU Medical said it has not received any adverse event reports.
More articles on supply chain:
FDA warns of critical medical device shortages
UPS expanding healthcare warehouse, distribution network
FDA warns of blood leak risk with endografts
Becker’s 3rd Annual Fall Chief Pharmacy Officer Summit is the top tier event that the people leading the future of pharmacy convene. This 3-day event is built specifically for Chief Pharmacy Officers and senior pharmacy leaders. The sessions examine the workforce, financial and clinical priorities shaping pharmacy today. Becker’s is where candid discussions flourish and new ideas thrive. Becker's 3rd Annual Fall Chief Pharmacy Officer Summit
